Market News
.png)
6 min read | Updated on January 13, 2025, 08:06 IST
SUMMARY
HCLTech is slated to announce its December quarter results (Q3 FY25) today. According to analysts tracking the IT sector, the company is expected to outperform other industry peers in revenue and net profit growth due to favourable seasonality for its Products & Platform (P&P) business.
Stock list

At 7:28 AM, the GIFT Nifty futures were trading at 23,319, down 8.50 points, or 0.04%.
At 7:28 AM, the GIFT Nifty futures were trading at 23,319, down 8.50 points, or 0.04%. This implies that the NIFTY50 index will open 182 points lower today.
The company had posted a net profit of Rs 690.41 crore a year ago.
Its revenue from operations rose 17.68% to ₹15,972.55 crore during the quarter under review. It was ₹13,572.47 crore in the corresponding quarter of the last fiscal.
Avenue Supermarts CEO and Managing Director Neville Noronha said, "The Q3 FY 2025 same-store revenue growth for 2 years and older stores was at 8.3%. We continue to see the increased intensity in discounting in the FMCG category and the consequent impact to high turnover per square feet stores in metro towns".
Further, the company has announced a top-level management reshuffle with the appointment of Unilever's Anshul Asawa as its CEO Designate.
The incumbent Managing Director and CEO Neville Noronham, whose current term is ending in January 2026 - a year from now, will not be offering his candidature for renewal of his role, according to a statement from Avenue Supermarts.
It had a net profit of ₹92.01 crore in the October-December period a year ago.
Revenue from operations was up 8.4% at ₹287.33 crore in the December quarter. The company "achieved its highest-ever quarterly revenue in Q3 FY25, further solidifying its position as a leader in digital services," said Just Dial in its earnings statement.
Vodafone has sold 7.92 crore or 3% stake in Indus Towers and used ₹890 crore from the proceeds to clear lenders dues, the company said in a regulatory filing.
While the company's EBITDA improved by 14% YoY to ₹328 crore, the EBITDA margin in Q3 FY25 was 16% as against 17% in Q3 FY24.
The offer for sale (OFS) included an option to additionally sell up to 8.44 crore shares, or 6.50% equity.
“This relates to the cGMP inspection conducted by the agency between September 15 and 27, 2024. The inspection scope had included several biologics manufacturing units comprising one (1) drug substance and one (1) drug product manufacturing unit, one (1) medical device assembly unit, one (1) analytical quality control laboratory, two (2) microbiological control laboratories, and two (2) warehouses," the press release added.
The land is located on Sector 71, Southern Peripheral Road, Gurugram, Haryana.
"The company expects to be entitled to a free sale component of around 3.2 lakh sq. ft. (RERA Carpet area) from the development and redevelopment of the said land, as per the extant provisions of Development Control & Promotion Regulations for Greater Mumbai, 2034," the filing added.
About The Author
.png)
Next Story
What Is the Face Value of a Share?
What is Free Float Market Capitalisation? Meaning & Formula
What Is RBI MPC? Meaning, Members, Functions & Role
Explore Learning Centre
All topics · stocks, MFs, derivatives, IPOs